| lepromin r. |
see under test.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|---|
| lepromin t. |
(for certain types of leprosy): after intradermal injection of lepromin (q.v.), a positive reaction consists of a tuberculin-type reaction at 48 to 72 hours (Fernandez reaction) or a nodular, occasionally ulcerated, lesion at 3 to 4 weeks (Mitsuda reaction). The test is not diagnostic; a large fraction of the normal population exhibits lepromin reactivity owing to sensitivity to cross-reacting antigens. In individuals known to have leprosy, lepromin reactivity is indicative of tuberculoid leprosy or borderline leprosy near the tuberculoid end of the spectrum, whereas lack of reactivity is indicative of lepromatous leprosy or near-lepromatous disease.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| leprosarium |
a hospital or colony for the treatment and isolation of leprosy patients.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| leprosary |
leprosarium.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| leprostatic |
1. inhibiting the growth of Mycobacterium leprae. 2. an agent that inhibits the growth of Mycobacterium leprae.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|